Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Treatment Type
- 5.2. Patient Demographics
- 5.3. Severity of Hemophilia B
- 5.4. Distribution Channel
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment Type
- 6.1. Recombinant Factor IX Concentrates
- 6.2. Plasma-Derived Factor IX Concentrates
- 6.3. Gene Therapy
- 6.4. Extended Half-Life Factor IX
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Demographics
- 7.1. Pediatrics
- 7.2. Adults
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Severity of Hemophilia B
- 8.1. Mild Hemophilia B
- 8.2. Moderate Hemophilia B
- 8.3. Severe Hemophilia B
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 9.1. Hospitals
- 9.2. Specialty Clinics
- 9.3. Online Pharmacies
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Treatment Type, Patient Demographics, Severity of Hemophilia B, and Distribution Channel for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
- 20.1. uniQure (CSL Behring)
- 20.2. Pfizer
- 20.3. Hoffmann-La Roche Ltd
- 20.4. Octapharma
- 20.5. Sanofi
- 20.6. Bayer AG
- 20.7. Baxter
- 20.8. Swedish Orphan Biovitrum AB
- 20.9. Grifols International S.A
- 20.10. Kedrion Biopharma, Inc.
- 20.11. Biomarin Pharmaceutical, Inc.
- 20.12. Chugai Pharmaceutical
- 20.13. Biogen, Inc.
List of Tables
Table 1: Global Market US$ Mn & Unit Forecast by Region, 2019 to 2034
Table 2: Global Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 3: Global Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 4: Global Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 5: Global Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 6: North America Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 7: North America Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 8: North America Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 9: North America Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 10: North America Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 11: Latin America Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 12: Latin America Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 13: Latin America Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 14: Latin America Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 15: Latin America Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 16: Western Europe Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 17: Western Europe Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 18: Western Europe Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 19: Western Europe Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 20: Western Europe Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 21: Eastern Europe Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 22: Eastern Europe Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 23: Eastern Europe Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 24: Eastern Europe Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 25: Eastern Europe Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 26: East Asia Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 27: East Asia Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 28: East Asia Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 29: East Asia Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 30: East Asia Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 31: South Asia & Pacific Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 32: South Asia & Pacific Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 33: South Asia & Pacific Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 34: South Asia & Pacific Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 35: South Asia & Pacific Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
Table 36: MEA Market US$ Mn & Unit Forecast by Country, 2019 to 2034
Table 37: MEA Market US$ Mn & Unit Forecast by Treatment Type, 2019 to 2034
Table 38: MEA Market US$ Mn & Unit Forecast by Patient Demographics, 2019 to 2034
Table 39: MEA Market US$ Mn & Unit Forecast by Severity of Hemophilia B, 2019 to 2034
Table 40: MEA Market US$ Mn & Unit Forecast by Distribution Channel, 2019 to 2034
List of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Region, 2019 to 2034
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 29: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 30: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 31: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 32: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 33: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 34: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 35: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Treatment Type, 2019 to 2034
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Patient Demographics, 2019 to 2034
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Severity of Hemophilia B, 2019 to 2034
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Distribution Channel, 2019 to 2034
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn & Unit Projection by Country, 2019 to 2034
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF